bluebox home | Research commercialisation | Information for investors and industry | Start-up companies
A key strategy in the management of QUT's intellectual capital is the creation of new start-up companies. bluebox manages these activities via its guidance in identification and sourcing of investment, company/project management and board participation.
Intellectual property developed at QUT has been integral in the creation of many companies, six of which are highlighted below:
- Tissue Therapies Ltd
, with key technologies in novel growth factors and autologous cell therapies. - ImpediMed Ltd , a medical device company focusing on bioimpedance.
- Farmacule Bioindustries Pty Ltd , which is a molecular farming company.
- Evogenix Ltd provides advanced technologies to provide powerful new antibody therapeutics for world markets.
- AdAlta Pty Ltd , which is using a platform-technology approach to develop novel antibody and peptide-based therapeutics against select targets.
- Rail Innovation Australia Pty Ltd ,
a spin-off company created from the Cooperative Research Centre for Railway Engineering and Technologies (Rail CRC). bluebox is a shareholder in the company, which works with partners to commercialise the world-leading technologies developed in the Rail CRC, and is positioning itself as an industry leader in intellectual property transfer, commercialisation and the development of new technologies in collaborative partnerships with manufacturers and technology users.
DISCLAIMER: Content on this website is for information purposes only. It does not constitute nor is it intended to constitute the provision of financial product advice. You must conduct your own due diligence on any companies / technologies before making an investment. Please read our full disclaimer.
